Employees: 02 (2023.0)Legal category: Société à responsabilité limitée (sans autre indication)Size: PMECreation date: 2009-01-08 (17 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: SAINT-LAURENT-DE-CONDEL (14220), Calvados
PHARMACIE DE SAINT LAURENT : revenue, balance sheet and financial ratios
PHARMACIE DE SAINT LAURENT is a French company
founded 17 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in SAINT-LAURENT-DE-CONDEL (14220),
this company of category PME
shows in 2023 a revenue of 1.4 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DE SAINT LAURENT (SIREN 509815114)
Indicator
2025
2024
2023
2022
2021
2020
2019
2017
Revenue
N/C
N/C
1 398 703 €
N/C
1 262 604 €
N/C
N/C
1 168 844 €
Net income
43 301 €
57 761 €
61 779 €
88 128 €
80 284 €
69 695 €
78 652 €
92 678 €
EBITDA
N/C
N/C
83 405 €
N/C
118 136 €
N/C
N/C
147 184 €
Net margin
N/C
N/C
4.4%
N/C
6.4%
N/C
N/C
7.9%
Revenue and income statement
In 2025, PHARMACIE DE SAINT LAURENT generates positive net income of 43 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2025: 93 k€ -> 43 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
43 301 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 3%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 87%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
2.797%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
87.279%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DE SAINT LAURENT
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2019
2020
2021
2022
2023
2024
2025
Debt ratio
101.033
39.816
21.457
10.25
7.598
4.802
2.835
2.797
Financial autonomy
46.414
65.077
74.506
79.73
82.791
85.939
85.457
87.279
Repayment capacity
4.802
None
None
0.884
None
0.642
None
None
Cash flow / Revenue
9.044%
None%
None%
7.493%
None%
4.63%
None%
None%
Sector positioning
Debt ratio
2.82025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Excellent
In 2025, the debt ratio of PHARMACIE DE SAINT LAURENT (2.80) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
Financial autonomy
87.28%2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Excellent+12 pts over 3 years
In 2025, the financial autonomy of PHARMACIE DE SAINT LAURENT (87.3%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
Repayment capacity
0.64 years2023
2023
Q1: 0.95 years
Med: 3.58 years
Q3: 7.48 years
Excellent
In 2023, the repayment capacity of PHARMACIE DE SAINT LAURENT (0.64) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 191.99. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
191.991
Liquidity indicators evolution PHARMACIE DE SAINT LAURENT
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
286.803
189.035
160.035
160.267
188.64
190.496
174.729
191.991
Interest coverage
8.42
None
None
1.458
None
0.736
None
None
Sector positioning
Liquidity ratio
191.992025
2023
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Good
In 2025, the liquidity ratio of PHARMACIE DE SAINT LAURENT (191.99) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Interest coverage
0.74x2023
2023
Q1: 0.38x
Med: 2.71x
Q3: 6.47x
Average
In 2023, the interest coverage of PHARMACIE DE SAINT LAURENT (0.7x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DE SAINT LAURENT
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2019
2020
2021
2022
2023
2024
2025
Operating WCR
106 038 €
0 €
0 €
100 339 €
0 €
112 735 €
0 €
0 €
Inventory turnover (days)
33
0
0
33
0
28
0
0
Customer payment term (days)
4
0
0
5
0
5
0
0
Supplier payment term (days)
19
0
0
29
0
22
0
0
Positioning of PHARMACIE DE SAINT LAURENT in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE DE SAINT LAURENT is estimated at
687 841 €
(range 466 772€ - 1 079 318€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
466k€687k€1079k€
687 841 €Range: 466 772€ - 1 079 318€
NAF 5 année 2025
Valuation method used
Net Income Multiple
43 301 €
×
15.9x
=687 842 €
Range: 466 773€ - 1 079 318€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DE SAINT LAURENT with other companies in the same sector:
Frequently asked questions about PHARMACIE DE SAINT LAURENT
What is the revenue of PHARMACIE DE SAINT LAURENT ?
The revenue of PHARMACIE DE SAINT LAURENT in 2023 is 1.4 M€.
Is PHARMACIE DE SAINT LAURENT profitable?
Yes, PHARMACIE DE SAINT LAURENT generated a net profit of 43 k€ in 2025.
Where is the headquarters of PHARMACIE DE SAINT LAURENT ?
The headquarters of PHARMACIE DE SAINT LAURENT is located in SAINT-LAURENT-DE-CONDEL (14220), in the department Calvados.
Where to find the tax return of PHARMACIE DE SAINT LAURENT ?
The tax return of PHARMACIE DE SAINT LAURENT is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DE SAINT LAURENT operate?
PHARMACIE DE SAINT LAURENT operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart